Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973205 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 900
- Enrollment target
NCT01973205 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 900 participants.
The verdict
NCT01973205, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 900 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine
Interventions
- DRUG Placebo
- DRUG Acetaminophen 250 mg and Aspirin 250 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01973205
The ClinicalTrials.gov registry entry for NCT01973205 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01973205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01973205 about?
NCT01973205 is a clinical study titled "Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine". The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine
What is the current status of trial NCT01973205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 900 participants. The study started on 2013-10. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01973205?
The interventions under investigation include: Placebo (DRUG), Acetaminophen 250 mg and Aspirin 250 mg (DRUG).
Who is sponsoring clinical trial NCT01973205?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.